Novartis Accused of Paying Kickbacks for Exjade Sales

A Novartis AG (NOVN) unit was accused by the U.S. and a group of states of paying kickbacks to a specialty pharmacy to boost sales of Exjade, an iron-control drug that can cause kidney and liver failure. More on Bloomberg. Novartis is a Global Compact participant since 2000/07/26 and is considered as one of the organization's Founding Fathers. Novartis was a LEAD contributor (USD $65,000 +) to the Foundation of the Global Compact in 2013 and 2012, and a USD 10,000 contributor in 2010. In 2009, Novartis International AG signed the UN Global Compact's CEO Letter against Corruption!